JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr | ₹19 Cr | ₹15 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹8.12 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹9.27 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹15 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.12 Cr | -52.36 | |
Mar2023 | ₹17 Cr | 83.93 | |
Mar2022 | ₹9.27 Cr | -52.35 | |
Mar2021 | ₹19 Cr | 29.55 | |
Mar2020 | ₹15 Cr | - |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹500.1 Cr | 1.7% | -7.4% | 37.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 1.7% |
-7.4% |
37.1% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses